HIGHLIGHTS
- who: Ruihuan Chai et al. from the School of Pharmaceutical Sciences, Shenzhen University Health Science Center, Shenzhen, China have published the Article: Circadian Clock Genes Act as Diagnostic and Prognostic Biomarkers of Glioma: Clinic Implications for Chronotherapy, in the Journal: BioMed Research International of 17/02/2022
- what: The study provided a basis for optimizing clinical dosing regimens and chronotherapy for glioma. The authors systematically analyzed and explored the role of CCGs in the diagnosis, prognosis, and chronotherapy of glioma.
- how: The results indicated that among all cancers glioma was affected mostly by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.